Kyverna Therapeutics
- Biotech or pharma, therapeutic R&D
We develop life changing medicines for people with autoimmune disease. Kyverna is pioneering a durable disease-clearing approach aiming for deep B cell depletion, an immune system reset, and long-term remission in autoimmune diseases. We are developing next generation CAR T cell therapies, and have a differentiated fully human anti-CD19 CAR that was designed for improved safety,